ISRG targets fast-growing ambulatory surgery centers with lower-cost da Vinci systems, positioning for long-term procedure growth as care shifts beyond hospitals.
Intuitive Surgical should have multiple growth drivers in an underpenetrated industry that it dominates. HCA Healthcare is well-positioned to profit from increased demand for medical services.
Bamco Inc. NY lessened its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Ameriprise Financial Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 1.2% during the undefined quarter, according to the company in its most recent 13F filing with the
FORA Capital LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). T
Banque Transatlantique SA boosted its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 18.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
2Xideas AG raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 11.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $472.16, denoting a -1.48% move from the preceding trading day.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in Intuitive Surgical (ISRG). While the effectiveness of this highly sought-after metric is questionable,
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $479.27, marking a -2.76% move from the previous day.
ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.
Intuitive Surgical is initiated with a Buy rating and a $584.87 price target, reflecting 19% upside potential. ISRG's business model benefits from robust recurring revenues in consumables and services

Intuitive Surgical Stock: Buy, Sell, or Hold?

12:03am, Thursday, 12'th Mar 2026
Intuitive Surgical's fourth-quarter revenue increased 19% year over year. Management guided for a notable deceleration in worldwide da Vinci procedure growth in 2026.
Intuitive Surgical (ISRG) remains the robotic-assisted surgery market leader, with Q4 procedures up 18% and revenue rising 19% to $2.87 billion. ISRG's recurring revenue model, high margins, and $3B n
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE